chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Painful cysts in left hip, lower extremities, treated with antibiotics, anti-bacterial body wash and anti-bacterial ointment
About 10:10 am patient went to get her two final series of Hep A and Hep B.  When she was done a few minutes later she came over to me and said she didn't feel good and her head hurt. When I got up from my seat she feel over. I tried to sit her up and her eyes where rolling and her body temp was very hot her face was red. Then I help her sit and all of a sudden she went into convulsions made a funny gasping sound like she couldn't get any air then she went completely out. When she came to her eyes where dilated and she was very disoriented. It took about 20 minutes before we could get her to look at us with out her eyes wondering, and to have her skin cool to the touch. About 1 hour after she said her head didn't hurt, but she still was a little lathargic. The nurse was with us the whole 30 mins, she did not have to administer any thing to her.
Local reaction, soreness, redness. 9/27/17 spoke with doctor's office. Pt saw NP. Pt reported no fever, chills, drainage, etc. but did report pain, redness and edema.
I received the 1st dose of the  Moderna covid vaccine on 12/30/2020  at 5:15pm. I developed symptoms 12 hours later on 12/31/2020 of shivering sweating hot then cold , low grade fever of 99.2  99.6  and also had no energy at all felt very weak for 2 days didn't have energy to do anything. Then the  2nd day followed by  a horrible headache with a lot of head pressure the entire evening and little to no energy continued for 2 days after getting my shot.  I had Covid19 back in July towards the end of the month. So I wasn't sure if that's why I had developed the symptoms and got sick the way I did since having covid in the passed. I would like to get any answers you can provide me with would be helpful.  I'm scheduled to get my 2nd dose of the covid19  on 1/28/2021 just would like to prepare for my second round. Thanks!
Swelling & redness of arm. Tenderness of arm. Pain & itching of arm, now has ringworm on same arm.
No adeverse Event; 03-FEB-2021-Dose 1, 21-MAR-2021-Dose 2; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (03-FEB-2021-Dose 1, 21-MAR-2021-Dose 2) and NO ADVERSE EVENT (No adeverse Event) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product IBRUTINIB (IMBRUVICA) for Lymphocytic lymphoma and Waldenstrom's macroglobulinaemia.    Concurrent medical conditions included Lymphocytic lymphoma and Waldenstrom's macroglobulinaemia.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Apr-2022, the patient started IBRUTINIB (IMBRUVICA) (Oral) 420 milligram once a day. On 21-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (03-FEB-2021-Dose 1, 21-MAR-2021-Dose 2). On an unknown date, the patient experienced NO ADVERSE EVENT (No adeverse Event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (03-FEB-2021-Dose 1, 21-MAR-2021-Dose 2) and NO ADVERSE EVENT (No adeverse Event) outcome was unknown.            No concomitant and treatment medication were provided It was unknown if the patient was enrolled in COVID-19 vaccine trial This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in   This case was linked to MOD-2021-618975 (Patient Link).
HYPOTENSION 3/7/2023 &  1/30/2023  -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Numbness on the tongue as of 1/26/2021 at 4:30am. Able to taste. However, have to be cautious to not bite my tongue.
Left upper arm is swollen; hot to touch; very sore/Keep getting random sharp pains in arm; Left upper arm tight; itchy; Feels like the skin is stretched; Was very sick Saturday and Sunday; Fever; body aches; vomiting; diarrhea; Could not get up; This is a spontaneous report from a contactable consumer (patient). A 50-year-old non-pregnant female patient received bnt162b2 (COMIRNATY, formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 06Aug2021 at 03:45 PM (Batch/Lot Number: FC3180) as Dose 1, Single for COVID-19 immunization administered in Pharmacy or Drug Store. Medical history included Psoriasis, psoriatic arthritis, anemic, reflux from an unknown date and unknown if ongoing. Concomitant medication(s) included estradiol (ESTRADIOL) taken for an unspecified indication, start and stop date were not reported; omeprazole (OMEPRAZOLE) taken for an unspecified indication, start and stop date were not reported; ibuprofen (ADVIL [IBUPROFEN]) taken for an unspecified indication, start and stop date were not reported; paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported.The patient previously took tetracycline and experienced allergies, humira and experienced allergies. (allergies to Humira and tetracycline). The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Aug2021 at 12:30 PM, the patient experienced left upper arm is swollen, hot to touch, very sore/keep getting random sharp pains in arm, left upper arm tight, itchy, feels like the skin is stretched, was very sick saturday and sunday, Fever, body aches, vomiting, diarrhea and Could not get up. The patient not received any corrective treatment for events. The outcome of events were not recovered.  Follow-up attempts are completed. No further information is expected.
2 day h/o rash starting on face and spreading. Tactile temp, fussy.  Multiple papules, vesicles
Heart beating very rapidly on morning after vaccination.   Pulse rate according to fitness tracker range from 90 - 110bpm right after waking up (and I was  not walking around) lasting approximately  1 hour , dropping to around 85 bpm  for about 3 hours afterward.  Fever present.   pulse returned to normal range around 69-72 bpm after that time.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB lot # M032148, expiration date 18-APR-2019 (dose and route of administration were not reported). There was no adverse symptom reported. Administered doses of vaccines experienced the temperature excursion between 32 and 36 degrees Fahrenheit for 15 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA011008.
This spontaneous report as received from a pharmacist refers to a 71 year old female patient. Drug reaction and allergies was not provided. On an unknown date the patient was vaccinated with pneumococcal vaccine (manufacturer unknown. (Dose, strength, lot# and expiration date were not provided). On an unknown date the patient reported that she was received a pneumonia vaccine (brand, name and manufacturer were unspecified), every year, for the past 7 years, when she received her flu vaccine. No adverse effect reported. Additional information has been requested.
Information has been received from a physician concerning her father who on 10-NOV-2008 was vaccinated with a dose of PNEUMOVAC. Later that night the patient developed swelling redness at the injection site. The swelling and redness extended down the arm to the wrist. The patient sought medical attention via telephone. At the time of report the patient had not recovered. No further information is available.
Patient reported to feeling nauseous right after receiving the vaccine, and then fainted.  He was assessed by EMS and refused to be transported to the hospital.  He walked out with his wife after the event.
Janssen COVID-19 Vaccine 6 hours after injection, my temperature was 101.4, my head was pounding and every inch of my body hurt and felt nauseated. Now that it has been just over 24 hours, temperature 99.2, I still have body aches (not as severe) and feel nauseated.
Cough; Delirious; She woke up with the sweats, which she knew was not normal for her; Difficulty breathing; Laughing at nothing; Flu-like; Feel achy; Low grade fever; Chills; Tingling in the chest; Fatigue feeling; Second dose of vaccination was on 02Jul2021; Congestion; Wheezing; Other respiratory symptoms; This is a spontaneous report received from a contactable consumer (patient). A 57-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on the left arm on 02Jul2021 as dose 2, single, with route of administration unspecified, for COVID-19 immunization. Medical history included asthma since childhood, and anaphylaxis. The patient's concomitant medications were not reported. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 15May2021 (at the age of 57 years old) for COVID-19 immunization. On 02Jul2021, the patient had a fatigue feeling. On 05Jul2021, the patient was laughing at nothing; had flu-like; was feeling achy; low grade fever; chills; and tingling in the chest. On 06Jul2021, the patient had woken up with sweats, which she knew was not normal for her; difficulty breathing; and was delirious. On 07Jul2021, the patient had cough that lasted for a long time. On an unspecified date in 2021, the patient had congestion, wheezing and other respiratory symptoms. The patient had received the second dose of vaccination on 02Jul2021, when the first dose was received on 15May2021. The patient was encouraged by her sister to go to the emergency room, but went to the doctor instead (events had resulted into physician office visit). The patient had a chest x-ray on 30Jul2021 (results were not provided). The patient was doing puffs of albuterol as treatment for difficulty breathing, congestion, wheezing and other respiratory symptoms. The outcome of the events was recovering for 'fatigue feeling', 'laughing at nothing', 'flu-like' and 'feeling achy'; was recovered on an unspecified date in 2021 for 'difficulty breathing'; and was unknown for all the other events.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
3/5 at 1000:Chills, joint pain, muscle aches fatigue, fever (102). 3/11 at 0800: woke up with extreme dizziness.
Body aches, pains, tiredness; Body aches, pains, tiredness; This is a spontaneous report from a contactable consumer or other non-health care professional re-ported for female patient (reporter's niece). A 23-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot num-ber was not reported), via an unspecified route of administration (at the age of 23-years), adminis-tered in arm on 23May2021 as dose 2, single for COVID-19 immunization. Medical history included none and family history of diabetes mellitus the patient dad was diabetic, but caller does not know for sure from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration (at the age of 23-years), on an unspecified date as dose 1, single for COVID-19 immunization and stated that it was maybe 3 weeks before the second dose and experienced no reac-tion on previous exposure to drug. On an unspecified date, the patient experienced body aches, pains, tiredness. Reporter also mentioned that his niece developed minor adverse events after the second dose of the vaccine. Caller was not sure when this started for the patient but caller states that it did not go away completely right away but the patient told the caller that she is getting better, not getting worse. The adverse event does not result in emergency room and physician office. Reporter was calling for his niece had the second dose of the Pfizer COVID-19 vaccine 10 days ago. The day before yesterday, his niece had an appointment for the hepatitis B vaccine. By mistake, the pharmacist had administered the Pfizer COVID19 vaccine to his niece and now his niece is experiencing adverse events that are similar to the adverse events she has experienced during her Pfizer COVID-19 vaccine second dose. Reporter wanted to know how safe having a third dose of the Pfizer COVID-19 vaccine was and he wanted to know what to do at this point. The patient was taking Pfizer Covid 19 vaccine as preventative. The clinical outcome for the events was reported as recovering.  Information regarding the Lot/Batch number has been requested.
This spontaneous report received from a pharmacist of unknown age regarding self refers to a patient. The patient has FLAGYL allergy. The patient had no pertinent medical history. On 14-AUG-2013, the pharmacist while reconstituting and drawing up ZOSTAVAX, (lot number was J003359, expiry date 21-JUN-2014, route unknown) for a patient, she accidentally broke her needle and splashed about 0.3ml of reconstituted ZOSTAVAX onto her face and eyes. No concomitant medications were reported. On 14-AUG-2013, the patient experienced irritation and itchiness in her eyes. The patient did not take any treatment for the events. The patient did not seek medical attention. Additional information has been requested.
Dizziness. Dizziness started after the shot. At the beginning it was less. Since November 17 it worse. See attached.
7JUL93 pt had t105.6 R, limp, shaking, sz; seen by MD also had throat infect dx as staph
After 10 min. I had trouble breathing and could barely talk. My body felt heavy and my cheeks swelled up and my lip and cheek were twitching. Fingers/hands were shakey and body felt jittery.p
Dizzy; light headed; fever; chills; diarrhea; nausea.
pt recv vax12:00 & by 10PM pt arm & trunk swollen & flame red;covered w/hives;sent to local ER;24 hr p/vax skin all over body dark & bruised appearing;no diff breathing;no swollen tongue;
swollen lt central deltoid & tender small local flat rash 2x2 cm over infection site;
Tingling/numbing in the throat and tongue 4 hours post injection. Took 25mg Benadryl and symptoms dissipated within 30 minutes. Symptoms reappeared in 4 hours. Took 25mg Benadryl and symptoms dissipated. Slept through the night, woke the next morning to milder, but similar symptoms (tingling/number throat and tongue). Contacted general practitioner and she advised not to take the second dose.
Redness at injection site  on Jan 11 and over 2 days has increased in size extending from shoulder to antecubital fossa
Pt phoned in to clinic with complaints of severely swollen, red, itchy, tender left upper arm. Pt denies any systematic reactions at this time. Referred to follow-up with PCP, pt stated she is going to send him a picture of her arm per MD request. Per pt, Dr. instructed her to elevate, ice, and to take ibuprofen/anti-histamine as well. Pt stated it started getting much better last night and is going to follow-up with PCP for order to continue series or not.
Rash at injection site (upper right arm); Swollen glands in right armpit; Rash in armpit; Tiredness; Headache; Aches; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 17Apr2021 at 09:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included multivitamins (MANUFACTURER UNKNOWN) from an unknown date from an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 09:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 10:00, the patient experienced rash at injection site; upper right arm, swollen glands in right armpit with rash in armpit, tiredness, aches and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash at injection site; upper right arm, swollen glands in right armpit with rash in armpit, tiredness, aches and headache was not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Chills at 2 am. Fever of 100.4 at 6 am body aches and headache. Vomitting began at 1 pm, lasted until after 3 pm. Fever remained until 4/23. Fatigue continues. Slight headache still exists on 4/24.
approx 1 hour after receiving the covid booster shot, I had slurred speech, couldn't for a coherent sentence, had difficulty driving.  I believed I was having a stroke.
Patient complaint of dizziness . vital were taken  and water given , EKG was perform patient was transfer via ambulance to Christ Hospital for higher level care
Rash, palms of both hands and around fingers; Peeling of skin on palms of both hands and around fingers; Itching to palms of both hands and around fingers; This is a spontaneous report from a contactable consumer (patient). A 24-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection, Lot Number: E19269) via an unspecified route of administration in right upper arm on 16Feb2021 at 13:00 (age at vaccination 24 year) as dose 1, single for COVID-19 immunization. Vaccine was offered to her. First week at new company they offered it and she said yes. she wasn't on any medications that she wasn't already taking for years already, so no concomitant medications. Medical history was not reported. Prior Vaccinations (within 4 weeks) , AE(s) following prior vaccinations, Family Medical History Relevant to AE(s) were reported as None. On an unspecified date in Feb2021, the patient experienced rash, palms of both hands and around fingers, peeling of skin on palms of both hands and around fingers and itching to palms of both hands and around fingers. Therapeutic measures were taken as a result of rash, palms of both hands and around fingers, peeling of skin on palms of both hands and around fingers and itching to palms of both hands and around fingers. The patient went to the doctor that day who gave her a steroid cream (Triamcinolone 0.1 percent cream to use three times a day) to put on the peeling skin to help with the itching. NDC: 67877-251-30. Lot and Expiration date unknown. Patient visited physician office. The doctor was also the one who recommended that she call and report this event because it seemed related to the vaccine. she called because she just wants to report a reaction. States that when it appeared after her first vaccine she thought maybe she had gotten into something that caused it. Now that the rash has improved her skin was peeling in the area where the rash was on the palms of both hands and around the fingers. States after the first shot it was a small rash. Relevant Tests were reported as None. The outcome of the events rash, palms of both hands and around fingers and itching to palms of both hands and around fingers was recovering while the outcome of the rest of the event was not recovered.  No follow up attempts are possible. No further information is expected.
I had the vaccine at 0800 on 1/7/2021. At approximately 1300 hours day of vaccine began having diarrhea. At 0200 on the 8th began running 102+ tempature. I have ran a temp on and off all day and have now developed a dry cough.
ALMOST EXACTLY 24 HOURS LATER, FEVER 101, COLD CHILLS, TIRED, SLEEPY.  SLEPT 2 HOURS  WHEN I GOT HOME FROM WORK . GOT UP FROM NAP AND WENT TO BED.  ALL NORMAL IN THE MORNING.
metallic taste in mouth starting around 11:30 and lasting for 3 hours.  Metallic taste went away after 3 hours.
Info. has been received from a female PT who on approx 5/22/02 was vax'd w/a "booster dose' of Hep B vax recombinant. The PT reported that she received the Hep B vax recombinant series in 91, respectively. The PT also reported that post-vax, her arm had a "knot", was painful, swollen, and warm to touch. The outcome of the PT's events was unknown. It was unknown if the PT sought medical attention. No further info. is available.
The first 2 doses were given a year apart; No adverse event; Information received on 18NOV2019 from a consumer.  A patient was given "first 2 doses of BioThrax a year apart" (PT: Inappropriate schedule of product administration). No adverse event was reported following the administration of BioThrax. A consumer while approaching for the third shot of BioThrax, reported that the first two doses were given a year apart.  Action taken with BioThrax was not applicable.  The clinical outcome of the reported events was unknown.  Company Comment: As there was no AE reported in connection to the "Inappropriate schedule of product administration", the Company is unable to make a causality assessment.  There is limited information to fully evaluate the circumstances behind the inappropriate dosing schedule.; Sender's Comments: As there was no AE reported in connection to the "Inappropriate schedule of product administration", the Company is unable to make a causality assessment.  There is limited information to fully evaluate the circumstances behind the inappropriate dosing schedule.